Advanced Urothelial Carcinoma Clinical Trials in New Haven, Connecticut
2 recruitingNew Haven, Connecticut
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
Advanced Urothelial CarcinomaOral Drug AdministrationOpen Label
Flare Therapeutics Inc.120 enrolled12 locationsNCT05929235
Recruiting
Phase 2
Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma
Locally Advanced Urothelial CarcinomaOligo-metastaic Urothelial Carcinoma
Yale University32 enrolled1 locationNCT07048457